Sellas Life Sciences Group Inc (SLS) — Cash Flow-to-Debt Ratio
Sellas Life Sciences Group Inc (SLS) has a Cash Flow-to-Debt Ratio of -0.98x as of June 2026, meaning its operating cash flow of $-7.59 Million could theoretically repay -1% of its total liabilities ($7.73 Million) in one year. See Sellas Life Sciences Group Inc (SLS) financial flexibility to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Sellas Life Sciences Group Inc Cash Flow-to-Debt Ratio (2007–2025)
Historical debt coverage capacity for Sellas Life Sciences Group Inc across 19 annual periods. For the full cash flow conversion analysis, see how efficiently does Sellas Life Sciences Group Inc generate cash.
Annual Cash Flow-to-Debt Ratio for Sellas Life Sciences Group Inc (2007–2025)
Year-by-year debt coverage analysis for Sellas Life Sciences Group Inc. Check Sellas Life Sciences Group Inc (SLS) cash flow quality to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -3.80x | $-28.39 Million | $7.47 Million | ▼ -6.9% |
| 2024 | -3.55x | $-35.40 Million | $9.97 Million | ▼ -60.5% |
| 2023 | -2.21x | $-31.41 Million | $14.20 Million | ▼ -49.6% |
| 2022 | -1.48x | $-23.81 Million | $16.09 Million | ▲ +65.4% |
| 2021 | -4.28x | $-26.02 Million | $6.08 Million | ▼ -643.1% |
| 2020 | -0.58x | $-10.42 Million | $18.09 Million | ▲ +65.7% |
| 2019 | -1.68x | $-17.64 Million | $10.52 Million | ▲ +35.6% |
| 2018 | -2.61x | $-30.42 Million | $11.67 Million | ▼ -646.2% |
| 2017 | -0.35x | $-10.99 Million | $31.46 Million | ▲ +71.1% |
| 2016 | -1.21x | $-44.91 Million | $37.15 Million | ▼ -72.3% |
| 2015 | -0.70x | $-48.16 Million | $68.63 Million | ▲ +28.9% |
| 2014 | -0.99x | $-42.87 Million | $43.43 Million | ▼ -180.3% |
| 2013 | -0.35x | $-28.91 Million | $82.09 Million | ▲ +54.3% |
| 2012 | -0.77x | $-20.96 Million | $27.23 Million | ▼ -9.5% |
| 2011 | -0.70x | $-14.67 Million | $20.86 Million | ▲ +65.4% |
| 2010 | -2.03x | $-10.26 Million | $5.05 Million | ▲ +4.8% |
| 2009 | -2.14x | $-11.77 Million | $5.51 Million | ▲ +68.5% |
| 2008 | -6.78x | $-9.43 Million | $1.39 Million | ▼ -48.4% |
| 2007 | -4.57x | $-6.05 Million | $1.32 Million | — |